Industry Partnerships & Commercialization

The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.

SickKids Innovators

We help researchers at SickKids navigate commercialization pathways through tailored advice, contract negotiation, intellectual property protection, and more.

Find Support

Industry Partners

We enable industry partners and investors to tap into the robust innovation ecosystem at SickKids by facilitating research agreements, licensing deals, and start-up creation.

Partner With Us

Available Technologies

Our innovation database highlights current technologies from SickKids that are available for licensing, partnership, or other commercialization opportunities.

Browse Our Innovations

Transforming SickKids Innovation into Global Health Impact

At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.

We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.

Discover how we connect ideas, industry, and investors to create efficient pathways for commercializing research and technology developed at SickKids by watching our video!

Image of the Peter Gilgan Centre for Research and Learning Tower at 686 Bay Street

Tap Into the Innovation Ecosystem at the SickKids Research Institute

IP&C operates out of the Peter Gilgan Centre for Research and Learning and is a division of the SickKids Research Institute – the largest hospital-based pediatric health institute in Canada.

Canada's most research-intensive hospital

*Research Infosource 2019

Top 10 Canadian institutions for licensing revenue generated

*AUTM Licensing survey for FY 2022

Over 600 active patents, 232 US Patents issued

World's 2nd Best Pediatric Hospital

*Newsweek World’s Best Specialized Hospitals 2023

Learn more about The SickKids Research Institute

Latest News

Accelerating Innovation: IP&C’s Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids’ Projects
Accelerating Innovation: IP&C's Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids' Projects From exploring innovative approaches for epilepsy treatment, to introducing a device [...]
A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
Breaking new ground in glioblastoma research: A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma Years [...]
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Researchers at The Hospital for Sick Children (SickKids) have developed a novel [...]
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships Radiant Biotherapeutics, a revolutionary antibody platform company developing multi-valent, multi-specific therapeutics [...]